Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €36.15 ($38.87) and traded as high as €38.35 ($41.24). Fresenius Medical Care shares last traded at €37.43 ($40.25), with a volume of 1,303,398 shares traded.
Fresenius Medical Care Price Performance
The business’s fifty day moving average is €36.37 and its 200-day moving average is €36.15. The company has a debt-to-equity ratio of 81.28, a current ratio of 1.42 and a quick ratio of 0.80. The firm has a market cap of $11.35 billion, a PE ratio of 22.02, a P/E/G ratio of 0.40 and a beta of 0.94.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- Why Invest in Biotech Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- The 3 Best Retail Stocks to Shop for in August
- Generac Powers Ahead on the Electrification Mega-Trend
- What is Forex and How Does it Work?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.